Correlation Between Cizzle Biotechnology and Polar Capital

Can any of the company-specific risk be diversified away by investing in both Cizzle Biotechnology and Polar Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cizzle Biotechnology and Polar Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cizzle Biotechnology Holdings and Polar Capital Technology, you can compare the effects of market volatilities on Cizzle Biotechnology and Polar Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cizzle Biotechnology with a short position of Polar Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cizzle Biotechnology and Polar Capital.

Diversification Opportunities for Cizzle Biotechnology and Polar Capital

0.07

Correlation Coefficient

Cizzle Biotechnology  Polar Capital

Significant diversification

The 3 months correlation between Cizzle and Polar is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Cizzle Biotechnology Holdings and Polar Capital Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Polar Capital Technology and Cizzle Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cizzle Biotechnology Holdings are associated (or correlated) with Polar Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Polar Capital Technology has no effect on the direction of Cizzle Biotechnology i.e., Cizzle Biotechnology and Polar Capital go up and down completely randomly.

Pair Corralation between Cizzle Biotechnology and Polar Capital

Assuming the 90 days trading horizon Cizzle Biotechnology Holdings is expected to generate 2.79 times more return on investment than Polar Capital. However, Cizzle Biotechnology is 2.79 times more volatile than Polar Capital Technology. It trades about 0.08 of its potential returns per unit of risk. Polar Capital Technology is currently generating about 0.15 per unit of risk. If you would invest  155.00  in Cizzle Biotechnology Holdings on September 2, 2024 and sell it today you would earn a total of  25.00  from holding Cizzle Biotechnology Holdings or generate 16.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cizzle Biotechnology Holdings  vs.  Polar Capital Technology

Cizzle Biotechnology

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cizzle Biotechnology Holdings are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Cizzle Biotechnology exhibited solid returns over the last few months and may actually be approaching a breakup point.

Polar Capital Technology

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Polar Capital Technology are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Polar Capital exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cizzle Biotechnology and Polar Capital

The main advantage of trading using opposite Cizzle Biotechnology and Polar Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cizzle Biotechnology position performs unexpectedly, Polar Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Polar Capital will offset losses from the drop in Polar Capital's long position.

The idea behind Cizzle Biotechnology Holdings and Polar Capital Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.